Dyax Corp (DYAX)

38.41
Prev Close 38.41
Day Low/High 0.00 / 0.00
52 Wk Low/High 14.06 / 38.56
Avg Volume 3.66M
Exchange
Shares Outstanding 147.18M
Market Cap 5.65B
EPS -0.09
Div & Yield N.A. (N.A)

Latest News

Dyax Corp. Sets January 21, 2016 As Date Of Special Stockholder Meeting To Vote On Its Proposed Acquisition By Shire Plc

Dyax Corp. Sets January 21, 2016 As Date Of Special Stockholder Meeting To Vote On Its Proposed Acquisition By Shire Plc

Dyax Corp. (NASDAQ:DYAX) ("Dyax") today announced it has set a date for a special meeting of its stockholders to consider and vote on the previously announced proposed acquisition of Dyax by Shire plc and certain other...

Dyax Corp. Presents DX-4012 Data At The 2015 American Society Of Hematology Annual Meeting

Dyax Corp. Presents DX-4012 Data At The 2015 American Society Of Hematology Annual Meeting

Dyax Corp. (NASDAQ: DYAX) today announced a poster presentation describing preclinical data for DX-4012, the Company's fully human monoclonal antibody to activated Factor XII (Factor XIIa), was presented at the 57th...

Market News: Avago Technologies, Dyax Corp, PVH Corp

Market News: Avago Technologies, Dyax Corp, PVH Corp

The stock markets in the United States and other parts of the world declined today as investors were disappointed with the stimulus decision of the European Central Bank (ECB). Sign up for our free ne...

3 Drugs Stocks Moving The Industry Upward

3 Drugs Stocks Moving The Industry Upward

TheStreet highlights 3 stocks pushing the drugs industry higher today.

Dyax (DYAX) Moving On Heavy Volume In The Pre-Market Hours

Dyax (DYAX) Moving On Heavy Volume In The Pre-Market Hours

Trade-Ideas LLC identified Dyax (DYAX) as a pre-market mover with heavy volume candidate

OPEC Begins Meeting Today, Saudis May Cut Oil Production

OPEC Begins Meeting Today, Saudis May Cut Oil Production

Leaders of oil producing nations begin gathering in Vienna today for the OPEC meeting.

Trade-Ideas: Dyax (DYAX) Is Today's Post-Market Leader Stock

Trade-Ideas: Dyax (DYAX) Is Today's Post-Market Leader Stock

Trade-Ideas LLC identified Dyax (DYAX) as a post-market leader candidate

Dyax Corp. Announces Early Termination Of Hart-Scott-Rodino Waiting Period

Dyax Corp. Announces Early Termination Of Hart-Scott-Rodino Waiting Period

Dyax Corp. (NASDAQ: DYAX) ("Dyax") today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), applicable to its proposed acquisition by Shire...

Dyax Corp. Recognized As A

Dyax Corp. Recognized As A "Top Place To Work" By The Boston Globe For Second Year In A Row

Dyax Corp. (NASDAQ: DYAX), a biopharmaceutical company focused on the development and commercialization of novel biotherapeutics for unmet medical needs, today announced that it has been named one of the Top Places to...

'Mad Money' Lightning Round: Northrop Grumman, Lockheed Martin Both Terrific

'Mad Money' Lightning Round: Northrop Grumman, Lockheed Martin Both Terrific

Cramer likes Johnson & Johnson, Stryker and Edwards Lifesciences, while avoiding all Chinese stocks.

Jim Cramer's 'Mad Money' Recap: Winners Remain When Rates Rise

Jim Cramer's 'Mad Money' Recap: Winners Remain When Rates Rise

When interest rates begin to rise, it may be harder to find winners, Cramer said. But only a pessimist would stop looking.

EQUITY ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Dyax Corp. That It Has Commenced An Investigation Challenging The Fairness Of The Sale Of The Company To Shire Plc

EQUITY ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Dyax Corp. That It Has Commenced An Investigation Challenging The Fairness Of The Sale Of The Company To Shire Plc

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Dyax Corp.

Dyax Corp. Presents Phase 1b DX-2930 Data At The American College Of Allergy, Asthma, And Immunology Annual Meeting

Dyax Corp. Presents Phase 1b DX-2930 Data At The American College Of Allergy, Asthma, And Immunology Annual Meeting

Dyax Corp. (NASDAQ:DYAX) today announced that two oral presentations describing clinical data from its DX-2930 Phase 1b study were presented at the American College of Allergy, Asthma, and Immunology (ACAAI) Annual Meeting...

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Dyax Corp. And Encourages Investors To Contact The Firm For Additional Information

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Dyax Corp. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Dyax...

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces The Investigation Of Dyax Corp. (DYAX) Over The Proposed Sale Of The Company To Shire Plc.

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces The Investigation Of Dyax Corp. (DYAX) Over The Proposed Sale Of The Company To Shire Plc.

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Dyax Corp.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Dyax Corp. Of Commencement Of An Investigation Concerning The Fairness Of The Sale Of The Company To Shire Plc -- DYAX

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Dyax Corp. Of Commencement Of An Investigation Concerning The Fairness Of The Sale Of The Company To Shire Plc -- DYAX

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Dyax Corp.

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Dyax Corp. And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Dyax Corp. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Dyax...

Dyax Corp. Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Merger With Shire Plc

Dyax Corp. Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Merger With Shire Plc

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Dyax Corp.

Buy These Biotechs Before They Bounce

Here are some mid-cap names with solid upside potential.

Stock Futures Are Edging Lower

Stock Futures Are Edging Lower

Stock futures edge lower after Monday's rally, though remain close to all-time highs.

Jim Cramer's 'Mad Money' Recap: Here's How You Make Money on Value

Jim Cramer's 'Mad Money' Recap: Here's How You Make Money on Value

Big investors are willing to pay a lot more for a host of companies for a multitude of different reasons, Cramer says.

Market News: Dyax Corp, Pfizer Inc, HP Inc

Market News: Dyax Corp, Pfizer Inc, HP Inc

The stock market in the United States gained today amid corporate transactions in the healthcare sector. Shire PLC agreed to acquire Dyan Corp. On the other hand, Pfizer was reportedly making progress...

Closing Bell: HP Inc. Up on Hewlett-Packard Split; Stocks Rally

Closing Bell: HP Inc. Up on Hewlett-Packard Split; Stocks Rally

U.S. markets ended Monday's session in the green as deal news boosted the health care sector following Shire's announcement that it would acquire drugmaker Dyax.

Stocks Rally to Begin 'Pivotal' Week for Rates Outlook

Stocks Rally to Begin 'Pivotal' Week for Rates Outlook

November extends October's stellar run in the beginning of what will be a crucial week for Federal Reserve watchers.

Stocks Extend Gains as Health Care Leads

Stocks Extend Gains as Health Care Leads

Stocks extend gains Monday afternoon as the health care sector rallies.

4 Big Stocks on Traders' Radars: Buy, Sell or Hold?

4 Big Stocks on Traders' Radars: Buy, Sell or Hold?

Here's a technical look at how to trade some of the most active stocks on the market right now.

Drug Giant Shire Snaps Up Biotech Dyax for $5.9 Billion

Drug Giant Shire Snaps Up Biotech Dyax for $5.9 Billion

The Dublin-based pharmaceutical will use the deal to bolster its rare disease drug portfolio, and says it can still afford to bid on larger target Baxalta.